518 First-in-human results with the novel tumor-targeting antibody ATRC-101: phase 1b study in patients with solid tumors
- DOI
- 10.1136/jitc-2021-sitc2021.518
- Published
- 2021-11
- Container
- Regular and Young Investigator Award Abstracts
- Publisher
- BMJ Publishing Group Ltd
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/jitc-2021-sitc2021.518,
title = {518 First-in-human results with the novel tumor-targeting antibody ATRC-101: phase 1b study in patients with solid tumors},
author = {John Powderly and Jeremy Jones and Tanios Bekaii-Saab and Yan Xing and S John Weroha and Susanna Ulahannan and Deborah Doroshow and Frances Valdes-Albini and Carl Millward and Kimberly Walter and Andrew Wrong and Paul Del Castillo and Lixia Wang and Ngan Nguyen and Mark Whidden and Jonathan Benjamin and Steven Isakoff},
year = {2021},
journal = {Regular and Young Investigator Award Abstracts},
doi = {10.1136/jitc-2021-sitc2021.518},
url = {https://doi.org/10.1136/jitc-2021-sitc2021.518}
}RIS
TY - JOUR TI - 518 First-in-human results with the novel tumor-targeting antibody ATRC-101: phase 1b study in patients with solid tumors AU - John Powderly AU - Jeremy Jones AU - Tanios Bekaii-Saab AU - Yan Xing AU - S John Weroha AU - Susanna Ulahannan AU - Deborah Doroshow AU - Frances Valdes-Albini AU - Carl Millward AU - Kimberly Walter AU - Andrew Wrong AU - Paul Del Castillo AU - Lixia Wang AU - Ngan Nguyen AU - Mark Whidden AU - Jonathan Benjamin AU - Steven Isakoff PY - 2021 JO - Regular and Young Investigator Award Abstracts DO - 10.1136/jitc-2021-sitc2021.518 UR - https://doi.org/10.1136/jitc-2021-sitc2021.518 ER -
APA
Powderly, J., Jones, J., Bekaii-Saab, T., Xing, Y., Weroha, S. J., Ulahannan, S., Doroshow, D., Valdes-Albini, F., Millward, C., Walter, K., Wrong, A., Castillo, P. D., Wang, L., Nguyen, N., Whidden, M., Benjamin, J., & Isakoff, S. (2021). 518 First-in-human results with the novel tumor-targeting antibody ATRC-101: phase 1b study in patients with solid tumors. Regular and Young Investigator Award Abstracts. https://doi.org/10.1136/jitc-2021-sitc2021.518
Source records
- crossref · retrieved 2026-09-26T11:46:42.088Z